Year
DEALS // DEV.
Country
Therapeutic Area
Study Phase
Deal Type
Product Type
Dosage Form
Lead Product
Target
Lead Product(s) : Buprenorphine
Therapeutic Area : Psychiatry/Psychology
Study Phase : Preclinical
Sponsor : National Institute on Drug Abuse
Deal Size : $15.0 million
Deal Type : Funding
Akyso Therapeutics Expands Pipeline with New NIH Grant for Buprenorphine Implant
Details : The proceeds will be used to develop iSTEP-B, a buprenorphine-based implant aimed at continuous treatment for OUD for up to a year.
Product Name : iSTEP-B
Product Type : Controlled Substance
Upfront Cash : Undisclosed
August 05, 2025
Lead Product(s) : Buprenorphine
Therapeutic Area : Psychiatry/Psychology
Highest Development Status : Preclinical
Sponsor : National Institute on Drug Abuse
Deal Size : $15.0 million
Deal Type : Funding
Reset All
